Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

4.96
Delayed Data
As of Feb 22
 -0.10 / -1.98%
Today’s Change
1.91
Today|||52-Week Range
5.89
+35.15%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +20.97% increase from the last price of 4.96.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.12
Sales
$4.5M
Reporting Date
May 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 50.00%
 
 
 
 
 
 
Growthannually 2.42%
 
 
 
 
 
 

Sales

Growthquarterly 1,058.34%
 
 
 
 
 
 
Growthannually 549.50%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.